$14.80
-0.66-4.27%
At close: -
$15.54
0.745.00%
After Hours: 4:43 PM EDT
Comments
Loading...
Viridian Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VRDN | Benzinga
Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-1.040
Quarterly Revenue Estimate
$42.86K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$302.00K
Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics | -$0.79 | -$1.04 | — | — | $72.00K | $42.86K | — | — | 05/07/2025 | Get Alert |
| VRDN | Viridian Therapeutics | -$0.97 | -$1.00 | -$0.81 | 19.00% | $72.00K | $48.77K | $72.00K | 47.63% | 02/27/2025 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.09 | -$1.05 | -$1.15 | -9.52% | $72.00K | $40.00K | $86.00K | 115.00% | 11/12/2024 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.27 | -$0.89 | -$1.02 | -14.61% | $72.00K | $90.00K | $72.00K | -20.00% | 08/08/2024 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.61 | -$1.10 | -$0.79 | 28.18% | $98.00K | $70.00K | $72.00K | 2.86% | 05/08/2024 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.13 | -$1.00 | -$1.35 | -35.00% | $105.00K | — | $72.00K | — | 02/27/2024 | Get Alert |
| VRDN | Viridian Therapeutics | -$0.86 | -$1.24 | -$1.09 | 12.10% | $1.20M | $110.00K | $72.00K | -34.55% | 11/13/2023 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.06 | -$1.29 | -$1.27 | 1.55% | $256.00K | $220.00K | $72.00K | -67.27% | 08/08/2023 | Get Alert |
| VRDN | Viridian Therapeutics | -$0.98 | -$1.02 | -$1.61 | -57.84% | $216.00K | $110.00K | $98.00K | -10.91% | 05/09/2023 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.32 | -$0.73 | -$1.13 | -54.79% | $214.00K | $510.00K | $105.00K | -79.41% | 03/08/2023 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.25 | -$0.95 | -$0.86 | 9.47% | $208.00K | $260.00K | $1.20M | 359.62% | 11/14/2022 | Get Alert |
| VRDN | Viridian Therapeutics | -$2.21 | -$0.90 | -$1.06 | -17.78% | $1.09M | $230.00K | $256.00K | 11.30% | 08/15/2022 | Get Alert |
| VRDN | Viridian Therapeutics | -$2.91 | -$1.08 | -$0.98 | 9.26% | $1.45M | $300.00K | $216.00K | -28.00% | 05/12/2022 | Get Alert |
| VRDN | Viridian Therapeutics | -$5.31 | -$0.90 | -$1.32 | -46.67% | $54.00K | $290.00K | $214.00K | -26.21% | 03/10/2022 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.48 | -$1.47 | -$1.25 | 14.97% | $0.00 | $450.00K | $208.00K | -53.78% | 11/04/2021 | Get Alert |
| VRDN | Viridian Therapeutics | -$1.82 | -$1.52 | -$2.21 | -45.39% | $168.00K | — | $1.09M | — | 08/11/2021 | Get Alert |
| VRDN | Viridian Therapeutics | -$2.65 | -$0.76 | -$2.91 | -282.89% | $828.00K | — | $1.45M | — | 05/06/2021 | Get Alert |
| VRDN | Viridian Therapeutics | -$0.31 | -$0.61 | -$5.31 | -770.49% | $880.00K | $80.00K | $54.00K | -32.50% | 03/25/2021 | Get Alert |
| VRDN | Viridian Therapeutics | -$0.36 | -$0.13 | -$0.10 | 23.08% | $695.00K | $150.00K | $0.00 | -100.00% | 11/10/2020 | Get Alert |
| VRDN | Viridian Therapeutics | -$0.29 | -$0.16 | -$0.12 | 25.00% | $2.51M | $520.00K | $168.00K | -67.69% | 08/05/2020 | Get Alert |
| VRDN | Viridian Therapeutics | -$0.38 | -$0.19 | -$0.18 | 5.26% | $372.00K | $580.00K | $828.00K | 42.76% | 05/07/2020 | Get Alert |
Viridian Therapeutics (VRDN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.81 | $-1.00 | 19.0 % |
| Q3 | 2024-11-12 | $-1.15 | $-1.05 | -9.52 % |
| Q2 | 2024-08-08 | $-1.02 | $-0.89 | -14.6 % |
| Q1 | 2024-05-08 | $-0.79 | $-1.10 | 28.2 % |
Viridian Therapeutics (VRDN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $72.00K | $48.77K | 47.6 % |
| Q3 | 2024-11-12 | $86.00K | $40.00K | 115.0 % |
| Q2 | 2024-08-08 | $72.00K | $90.00K | -20.0 % |
| Q1 | 2024-05-08 | $72.00K | $70.00K | 2.86 % |
FAQ
When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?
Viridian Therapeutics (VRDN) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?
The Actual EPS was $-0.81, which beat the estimate of $-1.00.
What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?
The Actual Revenue was $72K, which beat the estimate of $48.8K.
Browse earnings estimates, EPS, and revenue on all stocks.